John D Halpern - Net Worth and Insider Trading
John D Halpern Net Worth
The estimated net worth of John D Halpern is at least $568,469 dollars as of 2024-09-20. John D Halpern is the 10% Owner of Eterna Therapeutics Inc and owns about 451,166 shares of Eterna Therapeutics Inc (ERNA) stock worth over $568,469. Details can be seen in John D Halpern's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John D Halpern has not made any transactions after 2022-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John D Halpern
John D Halpern Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John D Halpern owns 1 companies in total, including Eterna Therapeutics Inc (ERNA) .
Click here to see the complete history of John D Halpern’s form 4 insider trades.
Insider Ownership Summary of John D Halpern
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ERNA | Eterna Therapeutics Inc | 2022-12-02 | 10 percent owner |
John D Halpern Latest Holdings Summary
John D Halpern currently owns a total of 1 stock. John D Halpern owns 451,166 shares of Eterna Therapeutics Inc (ERNA) as of December 2, 2022, with a value of $568,469.
Latest Holdings of John D Halpern
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ERNA | Eterna Therapeutics Inc | 2022-12-02 | 451,166 | 1.26 | 568,469 |
Holding Weightings of John D Halpern
John D Halpern Form 4 Trading Tracker
According to the SEC Form 4 filings, John D Halpern has made a total of 1 transactions in Eterna Therapeutics Inc (ERNA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eterna Therapeutics Inc is the acquisition of 335,920 shares on December 2, 2022, which cost John D Halpern around $1 Million.
Insider Trading History of John D Halpern
- 1
John D Halpern Trading Performance
GuruFocus tracks the stock performance after each of John D Halpern's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John D Halpern is 13.64%. GuruFocus also compares John D Halpern's trading performance to market benchmark return within the same time period. The performance of stocks bought by John D Halpern within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John D Halpern's insider trading performs compared to the benchmark.
Performance of John D Halpern
John D Halpern Ownership Network
John D Halpern Owned Company Details
What does Eterna Therapeutics Inc do?
Who are the key executives at Eterna Therapeutics Inc?
John D Halpern is the 10 percent owner of Eterna Therapeutics Inc. Other key executives at Eterna Therapeutics Inc include 10 percent owner Charles Cherington , 10 percent owner Freebird Investments Llc , and 10 percent owner Freebird Partners Lp .
Eterna Therapeutics Inc (ERNA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Eterna Therapeutics Inc (ERNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eterna Therapeutics Inc (ERNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Eterna Therapeutics Inc (ERNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eterna Therapeutics Inc Insider Transactions
John D Halpern Mailing Address
Above is the net worth, insider trading, and ownership report for John D Halpern. Currently GuruFocus does not have mailing address information for John D Halpern.